Factors Associated with the Use of Intermittent Preventive Treatment (IPTp) by Women During Pregnancy in Burkina Faso

Aristide Romaric Bado; Hermann Badolo; Mwinonè Hervé Hien; Ibrahim Lougué; Sathiyasusuman Appunni; Nicolas Méda

doi:doi:10.11648/j.wjph.20210603.15

| Peer-Reviewed

Factors Associated with the Use of Intermittent Preventive Treatment (IPTp) by Women During Pregnancy in Burkina Faso

Aristide Romaric Bado, Hermann Badolo, Mwinonè Hervé Hien, Ibrahim Lougué, Sathiyasusuman Appunni, Nicolas Méda

Published in World Journal of Public Health (Volume 6, Issue 3)

Received: 9 July 2021 Accepted: 4 August 2021 Published: 12 August 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Introduction: Malaria infection during pregnancy is more pronounced in endemic areas of sub-Saharan Africa and is a major risk factor for maternal and child morbidity and mortality. Intermittent preventive treatment in pregnancy (IPTp) is presented as an effective way of combating malaria. This study aims to identify the different factors that may influence the use of IPTp by pregnant women in Burkina Faso. Methods: The data used in this study were derived from two rounds of the Malaria Indicator Surveys (MISs) conducted in Burkina Faso in 2014 and 2017. The sample for this study consisted of women aged 15–49 years who had had a live birth in the two years prior to the survey and who might or might not have received IPTp doses. Data analysis was performed using the Stata 15 software. Bivariate analysis and a logistic regression model were used to determine the associated factors. Results: The study results show that 56% and 63% of pregnant women had received at least three or more doses of IPTp during pregnancy in 2014 and 2017, respectively. For the 2014 survey, religion, education level, household standard of living, region of residence and type of caregiver were the significant factors associated with receiving three or more doses of IPTp, while those in the 2017 survey were household standard of living, region of residence and access to malaria information. Conclusion: Plausible interventions to increase the reception of at least three doses of IPTp during pregnancy by explaining the benefits of SP could help to effectively control malaria in women and thus increase foetal and infant survival at birth.

Published in	World Journal of Public Health (Volume 6, Issue 3)
DOI	10.11648/j.wjph.20210603.15
Page(s)	110-120
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Determinants, Intermittent Preventive Treatment (IPTp), Malaria, Pregnancy, Chemoprevention, Burkina Faso

References

[1]	Desai M, Ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007; 7: 93–104.
[2]	Amoran OE, Ariba AA, Iyaniwura CA. Determinants of intermittent preventive treatment of malaria during pregnancy (IPTp) utilization in a rural town in Western Nigeria. Reprod Health 2012; 9: 1–8. https://doi.org/10.1186/1742-4755-9-12.
[3]	Guyatt HL, Snow RW. Impact of Malaria during Pregnancy on Low Birth Weight in Sub-Saharan Africa. Clin Microbiol Rev 2004; 17: 760–9. https://doi.org/10.1128/CMR.17.4.
[4]	WHO. Programme mondial de lutte antipaludique : Recommandation de politique générale de l’OMS : Chimioprévention du paludisme saisonnier pour lutter contre le paludisme à Plasmodium falciparum en zone de forte transmission saisonnière dans la sous- région du S 2012; 2011: 1–4.
[5]	Kibusi SM, Kimunai E, Hines CS. Predictors for uptake of intermittent preventive treatment of malaria in pregnancy (IPTp) in Tanzania. BMC Public Health 2015; 15: 1–8. https://doi.org/10.1186/s12889-015-1905-0.
[6]	Garner P, Gulmezoglu A. Drugs for preventing malaria-related illness in pregnant women and death in the newborn. Cochrane Database Syst Rev 2002. https://doi.org/10.1002/14651858.cd000169.
[7]	Agboghoroma CO. Current management and prevention of malaria in pregnancy: a review. West Afr J Med 2014; 33: 91–9.
[8]	Mcclure EM, Goldenberg RL, Dent AE, Meshnick SR. A systematic review of the impact of malaria prevention in pregnancy on low birth weight and maternal anemia. Int J Gynecol Obstet 2013; 121: 103–9. https://doi.org/10.1016/j.ijgo.2012.12.014.
[9]	World Health Organization. Global technical strategy for malaria 2016-2030. World Health Organization; 2015.
[10]	Ministere de la Santé du Burkina Faso. Etat de Santé la population du Burkina Faso. 2020.
[11]	Institut National de la Statistique et de la Démographie (INSD) et ICF International. Enquete sur les Indicateurs du Paludisme (EIPBF) au Burkina Faso 2014 2015.
[12]	Institut National de la Statistique et de la Démographie (INSD) Programme d’Appui au Développement Sanitaire (PADS) Programme National de Lutte contre le Paludisme (PNLP) et ICF. Enquête sur les indicateurs du paludisme au Burkina Faso, 2017-2018 2018.
[13]	Pell C, Straus L, Andrew EVW, Meñaca A, Pool R. Social and cultural factors affecting uptake of interventions for malaria in pregnancy in Africa: A systematic review of the qualitative research. PLoS One 2011; 6. https://doi.org/10.1371/journal.pone.0022452.
[14]	Ndyomugyenyi R, Katamanywa J. Intermittent preventive treatment of malaria in pregnancy (IPTp): Do frequent antenatal care visits ensure access and compliance to IPTp in Ugandan rural communities? Trans R Soc Trop Med Hyg 2010; 104: 536–40. https://doi.org/10.1016/j.trstmh.2010.02.003.
[15]	WHO. WHO policy brief for the Implementation of Intermittent Preventive Treatment of Malaria in Pregnancy Using Sulfadoxine-Pyrimethamine (IPTp-SP). WHO Press 2014: 1–13. https://doi.org/WHO/HTM/GMP/2014.4.
[16]	Kayentao K, Garner P, Maria van Eijk A, Naidoo I, Roper C, Mulokozi A, et al. Intermittent Preventive Therapy for Malaria During Pregnancy Using 2 vs 3 or More Doses of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in Africa. JAMA 2013; 309: 594. https://doi.org/10.1001/jama.2012.216231.
[17]	Chikwasha V, Phiri I, Chimberengwa P, Bangure D, Rusakaniko S. Predictors of IPTp Uptake among Pregnant Women in in the 2010-2011 Zimbabwe Demographic and Health Survey. 2014.
[18]	Ministère de la santé du Burkina Faso. Plan stratégique national de lutte contre le paludisme 2016-2020. Ouagadougou, Burkina Faso: 2016.
[19]	Akinleye SO, Falade CO, Ajayi IO. Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: a cross-sectional study. BMC Pregnancy Childbirth 2009; 9: 28. https://doi.org/10.1186/1471-2393-9-28.
[20]	World Health Organization. Malaria Policy Advisory Committee Meeting. 16–18 September 2015, Geneva, Switzerland: 2015.
[21]	Yaya S, Uthman OA, Amouzou A, Bishwajit G. Use of intermittent preventive treatment among pregnant women in sub-Saharan Africa: Evidence from malaria indicator surveys. Trop Med Infect Dis 2018; 3. https://doi.org/10.3390/tropicalmed3010018.
[22]	Kemble SK, Davis JC, Nalugwa T, Njama-Meya D, Hopkins H, Dorsey G, et al. Prevention and treatment strategies used for the community management of childhood fever in Kampala, Uganda. Am J Trop Med Hyg 2006; 74: 999–1007. https://doi.org/10.4269/ajtmh.2006.74.999.
[23]	Gikandi PW, Noor AM, Gitonga CW, Ajanga AA, Snow RW. Access and barriers to measures targeted to prevent malaria in pregnancy in rural Kenya. Trop Med Int Heal 2008; 13: 208–17. https://doi.org/10.1111/j.1365-3156.2007.01992.x.
[24]	Holtz TH, Patrick Kachur S, Roberts JM, Marum LH, Mkandala C, Chizani N, et al. Use of antenatal care services and intermittent preventive treatment for malaria among pregnant women in Blantyre District, Malawi. Trop Med Int Heal 2004; 9: 77–82. https://doi.org/10.1046/j.1365-3156.2003.01170.x.
[25]	Mbonye AK, Hansen KS, Bygbjerg IC, Magnussen P. Intermittent preventive treatment of malaria in pregnancy: the incremental cost-effectiveness of a new delivery system in Uganda. Trans R Soc Trop Med Hyg 2008; 102: 685–93. https://doi.org/10.1016/j.trstmh.2008.04.016.
[26]	Hill J, Hoyt J, van Eijk AM, D’Mello-Guyett L, ter Kuile FO, Steketee R, et al. Factors Affecting the Delivery, Access, and Use of Interventions to Prevent Malaria in Pregnancy in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. PLoS Med 2013; 10. https://doi.org/10.1371/journal.pmed.1001488.
[27]	Florey L. Preventing malaria during pregnancy in sub-Saharan Africa: determinants of effective IPTp delivery. DHS Anal Stud 2013: x-pp.

Cite This Article

Plain Text BibTeX RIS

APA Style

Aristide Romaric Bado, Hermann Badolo, Mwinonè Hervé Hien, Ibrahim Lougué, Sathiyasusuman Appunni, et al. (2021). Factors Associated with the Use of Intermittent Preventive Treatment (IPTp) by Women During Pregnancy in Burkina Faso. World Journal of Public Health, 6(3), 110-120. https://doi.org/10.11648/j.wjph.20210603.15

Copy | Download

ACS Style

Aristide Romaric Bado; Hermann Badolo; Mwinonè Hervé Hien; Ibrahim Lougué; Sathiyasusuman Appunni, et al. Factors Associated with the Use of Intermittent Preventive Treatment (IPTp) by Women During Pregnancy in Burkina Faso. World J. Public Health 2021, 6(3), 110-120. doi: 10.11648/j.wjph.20210603.15

Copy | Download

AMA Style

Aristide Romaric Bado, Hermann Badolo, Mwinonè Hervé Hien, Ibrahim Lougué, Sathiyasusuman Appunni, et al. Factors Associated with the Use of Intermittent Preventive Treatment (IPTp) by Women During Pregnancy in Burkina Faso. World J Public Health. 2021;6(3):110-120. doi: 10.11648/j.wjph.20210603.15

Copy | Download

@article{10.11648/j.wjph.20210603.15,
  author = {Aristide Romaric Bado and Hermann Badolo and Mwinonè Hervé Hien and Ibrahim Lougué and Sathiyasusuman Appunni and Nicolas Méda},
  title = {Factors Associated with the Use of Intermittent Preventive Treatment (IPTp) by Women During Pregnancy in Burkina Faso},
  journal = {World Journal of Public Health},
  volume = {6},
  number = {3},
  pages = {110-120},
  doi = {10.11648/j.wjph.20210603.15},
  url = {https://doi.org/10.11648/j.wjph.20210603.15},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.wjph.20210603.15},
  abstract = {Introduction: Malaria infection during pregnancy is more pronounced in endemic areas of sub-Saharan Africa and is a major risk factor for maternal and child morbidity and mortality. Intermittent preventive treatment in pregnancy (IPTp) is presented as an effective way of combating malaria. This study aims to identify the different factors that may influence the use of IPTp by pregnant women in Burkina Faso. Methods: The data used in this study were derived from two rounds of the Malaria Indicator Surveys (MISs) conducted in Burkina Faso in 2014 and 2017. The sample for this study consisted of women aged 15–49 years who had had a live birth in the two years prior to the survey and who might or might not have received IPTp doses. Data analysis was performed using the Stata 15 software. Bivariate analysis and a logistic regression model were used to determine the associated factors. Results: The study results show that 56% and 63% of pregnant women had received at least three or more doses of IPTp during pregnancy in 2014 and 2017, respectively. For the 2014 survey, religion, education level, household standard of living, region of residence and type of caregiver were the significant factors associated with receiving three or more doses of IPTp, while those in the 2017 survey were household standard of living, region of residence and access to malaria information. Conclusion: Plausible interventions to increase the reception of at least three doses of IPTp during pregnancy by explaining the benefits of SP could help to effectively control malaria in women and thus increase foetal and infant survival at birth.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Factors Associated with the Use of Intermittent Preventive Treatment (IPTp) by Women During Pregnancy in Burkina Faso
AU  - Aristide Romaric Bado
AU  - Hermann Badolo
AU  - Mwinonè Hervé Hien
AU  - Ibrahim Lougué
AU  - Sathiyasusuman Appunni
AU  - Nicolas Méda
Y1  - 2021/08/12
PY  - 2021
N1  - https://doi.org/10.11648/j.wjph.20210603.15
DO  - 10.11648/j.wjph.20210603.15
T2  - World Journal of Public Health
JF  - World Journal of Public Health
JO  - World Journal of Public Health
SP  - 110
EP  - 120
PB  - Science Publishing Group
SN  - 2637-6059
UR  - https://doi.org/10.11648/j.wjph.20210603.15
AB  - Introduction: Malaria infection during pregnancy is more pronounced in endemic areas of sub-Saharan Africa and is a major risk factor for maternal and child morbidity and mortality. Intermittent preventive treatment in pregnancy (IPTp) is presented as an effective way of combating malaria. This study aims to identify the different factors that may influence the use of IPTp by pregnant women in Burkina Faso. Methods: The data used in this study were derived from two rounds of the Malaria Indicator Surveys (MISs) conducted in Burkina Faso in 2014 and 2017. The sample for this study consisted of women aged 15–49 years who had had a live birth in the two years prior to the survey and who might or might not have received IPTp doses. Data analysis was performed using the Stata 15 software. Bivariate analysis and a logistic regression model were used to determine the associated factors. Results: The study results show that 56% and 63% of pregnant women had received at least three or more doses of IPTp during pregnancy in 2014 and 2017, respectively. For the 2014 survey, religion, education level, household standard of living, region of residence and type of caregiver were the significant factors associated with receiving three or more doses of IPTp, while those in the 2017 survey were household standard of living, region of residence and access to malaria information. Conclusion: Plausible interventions to increase the reception of at least three doses of IPTp during pregnancy by explaining the benefits of SP could help to effectively control malaria in women and thus increase foetal and infant survival at birth.
VL  - 6
IS  - 3
ER  -

Copy | Download

Author Information

Aristide Romaric Bado

Department of Biomedical and Public Health, Research Institute of Health Science, Ouagadougou, Burkina Faso
Hermann Badolo

National Institute of Public Health, Ouagadougou, Burkina Faso
Mwinonè Hervé Hien

Department of Biomedical and Public Health, Research Institute of Health Science, Ouagadougou, Burkina Faso
Ibrahim Lougué

Burkinabe Association for Family Welfare, Ouagadougou, Burkina Faso
Sathiyasusuman Appunni

Department of statistics and Population studies, University of the Western Cape, Cape Town, South Africa
Nicolas Méda

Department of Public Health, Faculty of Medicine, University Joseph Ki-Zerbo, Ouagadougou, Burkina Faso

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Aristide Romaric Bado, Hermann Badolo, Mwinonè Hervé Hien, Ibrahim Lougué, Sathiyasusuman Appunni, et al. (2021). Factors Associated with the Use of Intermittent Preventive Treatment (IPTp) by Women During Pregnancy in Burkina Faso. World Journal of Public Health, 6(3), 110-120. https://doi.org/10.11648/j.wjph.20210603.15

Copy | Download

ACS Style

Aristide Romaric Bado; Hermann Badolo; Mwinonè Hervé Hien; Ibrahim Lougué; Sathiyasusuman Appunni, et al. Factors Associated with the Use of Intermittent Preventive Treatment (IPTp) by Women During Pregnancy in Burkina Faso. World J. Public Health 2021, 6(3), 110-120. doi: 10.11648/j.wjph.20210603.15

Copy | Download

AMA Style

Aristide Romaric Bado, Hermann Badolo, Mwinonè Hervé Hien, Ibrahim Lougué, Sathiyasusuman Appunni, et al. Factors Associated with the Use of Intermittent Preventive Treatment (IPTp) by Women During Pregnancy in Burkina Faso. World J Public Health. 2021;6(3):110-120. doi: 10.11648/j.wjph.20210603.15

Copy | Download

@article{10.11648/j.wjph.20210603.15,
  author = {Aristide Romaric Bado and Hermann Badolo and Mwinonè Hervé Hien and Ibrahim Lougué and Sathiyasusuman Appunni and Nicolas Méda},
  title = {Factors Associated with the Use of Intermittent Preventive Treatment (IPTp) by Women During Pregnancy in Burkina Faso},
  journal = {World Journal of Public Health},
  volume = {6},
  number = {3},
  pages = {110-120},
  doi = {10.11648/j.wjph.20210603.15},
  url = {https://doi.org/10.11648/j.wjph.20210603.15},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.wjph.20210603.15},
  abstract = {Introduction: Malaria infection during pregnancy is more pronounced in endemic areas of sub-Saharan Africa and is a major risk factor for maternal and child morbidity and mortality. Intermittent preventive treatment in pregnancy (IPTp) is presented as an effective way of combating malaria. This study aims to identify the different factors that may influence the use of IPTp by pregnant women in Burkina Faso. Methods: The data used in this study were derived from two rounds of the Malaria Indicator Surveys (MISs) conducted in Burkina Faso in 2014 and 2017. The sample for this study consisted of women aged 15–49 years who had had a live birth in the two years prior to the survey and who might or might not have received IPTp doses. Data analysis was performed using the Stata 15 software. Bivariate analysis and a logistic regression model were used to determine the associated factors. Results: The study results show that 56% and 63% of pregnant women had received at least three or more doses of IPTp during pregnancy in 2014 and 2017, respectively. For the 2014 survey, religion, education level, household standard of living, region of residence and type of caregiver were the significant factors associated with receiving three or more doses of IPTp, while those in the 2017 survey were household standard of living, region of residence and access to malaria information. Conclusion: Plausible interventions to increase the reception of at least three doses of IPTp during pregnancy by explaining the benefits of SP could help to effectively control malaria in women and thus increase foetal and infant survival at birth.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Factors Associated with the Use of Intermittent Preventive Treatment (IPTp) by Women During Pregnancy in Burkina Faso
AU  - Aristide Romaric Bado
AU  - Hermann Badolo
AU  - Mwinonè Hervé Hien
AU  - Ibrahim Lougué
AU  - Sathiyasusuman Appunni
AU  - Nicolas Méda
Y1  - 2021/08/12
PY  - 2021
N1  - https://doi.org/10.11648/j.wjph.20210603.15
DO  - 10.11648/j.wjph.20210603.15
T2  - World Journal of Public Health
JF  - World Journal of Public Health
JO  - World Journal of Public Health
SP  - 110
EP  - 120
PB  - Science Publishing Group
SN  - 2637-6059
UR  - https://doi.org/10.11648/j.wjph.20210603.15
AB  - Introduction: Malaria infection during pregnancy is more pronounced in endemic areas of sub-Saharan Africa and is a major risk factor for maternal and child morbidity and mortality. Intermittent preventive treatment in pregnancy (IPTp) is presented as an effective way of combating malaria. This study aims to identify the different factors that may influence the use of IPTp by pregnant women in Burkina Faso. Methods: The data used in this study were derived from two rounds of the Malaria Indicator Surveys (MISs) conducted in Burkina Faso in 2014 and 2017. The sample for this study consisted of women aged 15–49 years who had had a live birth in the two years prior to the survey and who might or might not have received IPTp doses. Data analysis was performed using the Stata 15 software. Bivariate analysis and a logistic regression model were used to determine the associated factors. Results: The study results show that 56% and 63% of pregnant women had received at least three or more doses of IPTp during pregnancy in 2014 and 2017, respectively. For the 2014 survey, religion, education level, household standard of living, region of residence and type of caregiver were the significant factors associated with receiving three or more doses of IPTp, while those in the 2017 survey were household standard of living, region of residence and access to malaria information. Conclusion: Plausible interventions to increase the reception of at least three doses of IPTp during pregnancy by explaining the benefits of SP could help to effectively control malaria in women and thus increase foetal and infant survival at birth.
VL  - 6
IS  - 3
ER  -

Copy | Download